GW Pharmaceuticals to Report Q1 Financial Results and Host Conference Call on 7 February, 2017

LONDON, Jan. 30, 2017 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, will announce on 7 February, 2017 its first quarter financial results for the period ending 31 December, 2016. GW will also host a conference call the same day at 8:30 a.m. EST. Conference call information will be provided in the financial results press release. A replay of the call will also be available through the Company’s website (www.gwpharm.com) shortly after the call.

About GW Pharmaceuticals plc

Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. GW is advancing an

... read more at: http://www.nasdaq.com/press-release/gw-pharmaceuticals-to-report-q1-financial-results-and-host-conference-call-on-7-february-2017-20170130-00267

by